Next Article in Journal
Predicting Prostatic Obstruction and Bladder Outlet Dysfunction in Men with Lower Urinary Tract Symptoms and Small-to-Moderate Prostate Volume Using Noninvasive Diagnostic Tools
Previous Article in Journal
Interaction Between the VNTR of the DAT1 Gene and DAT1 Methylation in Relation to Impulsivity in Combat Sports Athletes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 13
Issue 12
10.3390/biomedicines13122895
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Biomedicines 2025, 13(2), 395.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Colarusso et al. Role of the AIM2 Inflammasome in Cancer: Potential Therapeutic Strategies. Biomedicines 2025, 13, 395

by
Chiara Colarusso
1,
Michela Terlizzi
1,
Simone Di Caprio
1,
Anna Falanga
1,
Emmanuel D’Andria
1,
Roberta d’Emmanuele di Villa Bianca
2 and
Rosalinda Sorrentino
1,*
1
Department of Pharmacy (DIFARMA), University of Salerno, 84084 Fisciano, SA, Italy
2
Department of Pharmacy, University of Naples Federico II, 80131 Naples, NA, Italy
*
Author to whom correspondence should be addressed.
Biomedicines 2025, 13(12), 2895; https://doi.org/10.3390/biomedicines13122895
Submission received: 11 September 2025 / Accepted: 24 September 2025 / Published: 27 November 2025
(This article belongs to the Section Molecular and Translational Medicine)
Versions Notes
Text Correction
In the original publication [1], as ref. 50 was retracted, it has been replaced with another reference. In this case, the main text has been revised accordingly.
A correction has been made to Section 2, Section 2.4, Paragraph 1:
Original text:
“In an in vitro study, knocking down AIM2 in HCC cells enhanced cell migration, the formation of cell pseudopodium, wound healing, and led to the activation of epithelial–mesenchymal transition (EMT) tumor metastasis, whereas the reintroduction of AIM2 attenuated these effects [50].”
Revised text:
“In addition, AIM2 overexpression inhibited HCC cell proliferation, migration, and invasion while promoting apoptosis and autophagy, effects that were blocked once AIM2 was knocked down [50].”
Reference
As ref. 50 was retracted, it has been replaced with another reference.
Original reference:
“50. Chen, S.L.; Liu, L.L.; Lu, S.X.; Luo, R.Z.; Wang, C.H.; Wang, H.; Cai, S.H.; Yang, X.; Xie, D.; Zhang, C.Z.; et al. HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis. Mol. Oncol. 2017, 11, 1225–1240”.
Revised reference:
“50. Xie, S.; Wang, C.; Liu, X.; Li, C.; Yu, J.; Ma, S.; Li, Q.; Du, W. Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization. Immun. Inflamm. Dis. 2024, 12, e70002”.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Colarusso, C.; Terlizzi, M.; Di Caprio, S.; Falanga, A.; D’Andria, E.; d’Emmanuele di Villa Bianca, R.; Sorrentino, R. Role of the AIM2 Inflammasome in Cancer: Potential Therapeutic Strategies. Biomedicines 2025, 13, 395. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Colarusso, C.; Terlizzi, M.; Di Caprio, S.; Falanga, A.; D’Andria, E.; d’Emmanuele di Villa Bianca, R.; Sorrentino, R. Correction: Colarusso et al. Role of the AIM2 Inflammasome in Cancer: Potential Therapeutic Strategies. Biomedicines 2025, 13, 395. Biomedicines 2025, 13, 2895. https://doi.org/10.3390/biomedicines13122895

AMA Style

Colarusso C, Terlizzi M, Di Caprio S, Falanga A, D’Andria E, d’Emmanuele di Villa Bianca R, Sorrentino R. Correction: Colarusso et al. Role of the AIM2 Inflammasome in Cancer: Potential Therapeutic Strategies. Biomedicines 2025, 13, 395. Biomedicines. 2025; 13(12):2895. https://doi.org/10.3390/biomedicines13122895

Chicago/Turabian Style

Colarusso, Chiara, Michela Terlizzi, Simone Di Caprio, Anna Falanga, Emmanuel D’Andria, Roberta d’Emmanuele di Villa Bianca, and Rosalinda Sorrentino. 2025. "Correction: Colarusso et al. Role of the AIM2 Inflammasome in Cancer: Potential Therapeutic Strategies. Biomedicines 2025, 13, 395" Biomedicines 13, no. 12: 2895. https://doi.org/10.3390/biomedicines13122895

APA Style

Colarusso, C., Terlizzi, M., Di Caprio, S., Falanga, A., D’Andria, E., d’Emmanuele di Villa Bianca, R., & Sorrentino, R. (2025). Correction: Colarusso et al. Role of the AIM2 Inflammasome in Cancer: Potential Therapeutic Strategies. Biomedicines 2025, 13, 395. Biomedicines, 13(12), 2895. https://doi.org/10.3390/biomedicines13122895

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop